Detalhe da pesquisa
1.
TIME for a successful cancer vaccine in NSCLC?
Lancet Oncol
; 17(2): 131-132, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26727164
2.
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
J Thorac Oncol
; 16(6): 960-967, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539971
3.
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.
Lung Cancer
; 157: 40-47, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980420
4.
Adjuvant therapy in non-small cell lung cancer: current and future directions.
Oncologist
; 15(8): 862-72, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20682608
5.
VeriStrat validated in patients with non-small-cell lung cancer.
Lancet Oncol
; 15(7): 671-2, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831978
6.
Extending outcomes: epidermal growth factor receptor-targeted monoclonal antibodies in non-small-cell lung cancer.
Clin Lung Cancer
; 10 Suppl 1: S24-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19362943
7.
Is lobectomy superior to sublobar resection for early-stage small-cell lung cancer discovered intraoperatively?
Interact Cardiovasc Thorac Surg
; 28(1): 41-44, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053292
8.
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
Clin Cancer Res
; 13(11): 3264-8, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545532
9.
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.
Clin Colorectal Cancer
; 5(2): 101-7, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16098250
10.
Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer.
Clin Lung Cancer
; 16(1): 33-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25246385
11.
Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer.
Lung Cancer
; 83(2): 211-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332319
12.
Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy.
Transl Lung Cancer Res
; 2(5): 415-22, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25806261
13.
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
J Clin Oncol
; 28(1): 29-34, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19933915
14.
Reply to V. Lorusso et al.
J Clin Oncol
; 31(2): 289-9, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23413460
15.
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
J Clin Oncol
; 25(25): 3936-44, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17761977
16.
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
J Clin Oncol
; 25(36): 5777-84, 2007 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18089875